Oppenheimer Asset Management Inc. Becton Dickinson & CO Transaction History

Oppenheimer Asset Management Inc.

  • $8.04 Billion
  • Q3 2024

A detailed history of Oppenheimer Asset Management Inc. transactions in Becton Dickinson & CO stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 27,469 shares of BDX stock, worth $6.18 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
27,469
Previous 27,567 0.36%
Holding current value
$6.18 Million
Previous $6.44 Million 2.79%
% of portfolio
0.08%
Previous 0.08%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024
SELL
$221.47 - $242.41 $21,704 - $23,756
-98 Reduced 0.36%
27,469 $6.62 Million
Q2 2024

Aug 08, 2024
SELL
$225.07 - $246.17 $2.76 Million - $3.02 Million
-12,256 Reduced 30.78%
27,567 $6.44 Million
Q1 2024

May 06, 2024
SELL
$233.45 - $247.73 $1.18 Million - $1.25 Million
-5,061 Reduced 11.28%
39,823 $9.85 Million
Q4 2023

Feb 13, 2024
SELL
$232.24 - $267.23 $193,920 - $223,137
-835 Reduced 1.83%
44,884 $10.9 Million
Q3 2023

Nov 07, 2023
SELL
$254.9 - $283.59 $3.68 Million - $4.09 Million
-14,418 Reduced 23.98%
45,719 $11.8 Million
Q2 2023

Aug 02, 2023
SELL
$238.39 - $265.32 $21,931 - $24,409
-92 Reduced 0.15%
60,137 $15.9 Million
Q1 2023

May 10, 2023
SELL
$229.71 - $259.35 $695,332 - $785,052
-3,027 Reduced 4.79%
60,229 $14.9 Million
Q4 2022

Feb 06, 2023
BUY
$218.29 - $256.91 $149,746 - $176,240
686 Added 1.1%
63,256 $16.1 Million
Q3 2022

Nov 14, 2022
BUY
$51.03 - $264.23 $125,584 - $650,270
2,461 Added 4.09%
62,570 $13.9 Million
Q2 2022

Aug 08, 2022
BUY
$234.74 - $275.42 $400,466 - $469,866
1,706 Added 2.92%
60,109 $14.8 Million
Q1 2022

May 12, 2022
BUY
$243.64 - $270.48 $517,247 - $574,229
2,123 Added 3.77%
58,403 $15.5 Million
Q4 2021

Feb 02, 2022
BUY
$230.08 - $250.94 $656,648 - $716,182
2,854 Added 5.34%
56,280 $14.2 Million
Q3 2021

Nov 12, 2021
BUY
$232.72 - $256.47 $756,805 - $834,040
3,252 Added 6.48%
53,426 $13.1 Million
Q2 2021

Aug 03, 2021
BUY
$232.65 - $254.58 $2.25 Million - $2.46 Million
9,680 Added 23.9%
50,174 $12.2 Million
Q1 2021

May 17, 2021
BUY
$232.09 - $256.88 $171,514 - $189,834
739 Added 1.86%
40,494 $9.85 Million
Q4 2020

Feb 11, 2021
BUY
$221.92 - $245.94 $229,021 - $253,810
1,032 Added 2.67%
39,755 $9.95 Million
Q3 2020

Nov 13, 2020
SELL
$215.77 - $276.76 $905,586 - $1.16 Million
-4,197 Reduced 9.78%
38,723 $9.01 Million
Q2 2020

Aug 11, 2020
BUY
$219.9 - $263.41 $2.58 Million - $3.09 Million
11,729 Added 37.6%
42,920 $10.3 Million
Q1 2020

May 08, 2020
BUY
$195.69 - $279.01 $2.12 Million - $3.03 Million
10,857 Added 53.39%
31,191 $7.17 Million
Q4 2019

Feb 07, 2020
SELL
$236.45 - $266.82 $615,715 - $694,799
-2,604 Reduced 11.35%
20,334 $5.53 Million
Q3 2019

Oct 31, 2019
SELL
$230.58 - $256.08 $994,030 - $1.1 Million
-4,311 Reduced 15.82%
22,938 $5.8 Million
Q2 2019

Aug 09, 2019
SELL
$217.4 - $246.08 $1.03 Million - $1.17 Million
-4,735 Reduced 14.8%
27,249 $6.87 Million
Q1 2019

Apr 24, 2019
SELL
$206.05 - $248.17 $1.83 Million - $2.2 Million
-8,875 Reduced 21.72%
31,984 $7.99 Million
Q4 2018

Jan 30, 2019
BUY
$204.73 - $257.93 $238,305 - $300,230
1,164 Added 2.93%
40,859 $9.21 Million
Q3 2018

Oct 26, 2018
BUY
$233.07 - $256.0 $245,189 - $269,312
1,052 Added 2.72%
39,695 $10.4 Million
Q2 2018

Aug 10, 2018
SELL
$208.1 - $233.85 $8,948 - $10,055
-43 Reduced 0.11%
38,643 $9.26 Million
Q1 2018

May 09, 2018
BUY
$205.46 - $240.27 $1.44 Million - $1.69 Million
7,027 Added 22.2%
38,686 $8.38 Million
Q3 2017

Nov 14, 2017
BUY
$186.89 - $198.9 $5.92 Million - $6.3 Million
31,659
31,659 $6.2 Million

Others Institutions Holding BDX

# of Institutions
1,735
Shares Held
250M
Call Options Held
690K
Put Options Held
787K
View Full List

About BECTON DICKINSON & CO

BDX Quotes by TradingView
  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64.2B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Oppenheimer Asset Management Inc. Portfolio

Follow Oppenheimer Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email